ArticleEuropean journal of haematology2021

Long-term tolerability of phosphodiesterase-5 inhibitors in pulmonary hypertension of sickle cell disease.

Cassondra Cramer-Bour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.